Beyrer C, Tomaras GD, Gelderblom HC, Gray GE, Janes HE, Bekker L-G, Millett G, Pantaleo G, Buchbinder S, Corey L. Is HIV epidemic control by 2030 realistic? Lancet HIV. 2024;11:e489–94. https://doi.org/10.1016/S2352-3018(24)00098-5.
Google Scholar
Chun HM, Dirlikov E, Cox MH, Sherlock MW, Obeng-Aduasare Y, Sato K, Voetsch AC, Ater AD, Romano ER, Tomlinson H, Modi S, Achrekar A, Nkengasong J. Vital signs: progress toward eliminating HIV as a global public health threat through Scale-Up of antiretroviral therapy and health system strengthening supported by the U.S. President’s emergency plan for AIDS Relief – Worldwide, 2004–2022. MMWR Morb Mortal Wkly Rep. 2023;72:317–24. https://doi.org/10.15585/mmwr.mm7212e1.
Google Scholar
The urgency of now: AIDS at a crossroads. Geneva: Joint United Nations Programme on HIV/AIDS; 2024. Licence: CC BY-NC-SA 3.0 IGO. https://www.unaids.org/en/resources/documents/2024/global-aids-update-2024
The path that ends AIDS: UNAIDS Global AIDS Update 2023. Geneva: Joint United Nations Programme on HIV/AIDS; 2023. Licence: CC BY-NC-SA 3.0 IGO. https://thepath.unaids.org/wp-content/themes/unaids2023/assets/files/2023_report.pdf
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021.
McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013;91:377–E385. https://doi.org/10.2471/BLT.12.112946.
Google Scholar
Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, Boesecke C, Patterson S, Grabar S, Cazanave C, Cavassini M, Shepherd L, Monforte A, van d’Arminio A, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Ingle SM, Sterne JAC. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–56. https://doi.org/10.1016/S2352-3018(17)30066-8.
Google Scholar
Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321:451–2. https://doi.org/10.1001/jama.2018.21167.
Google Scholar
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink H-J, Phillips AN, Lundgren J. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–38. https://doi.org/10.1016/S0140-6736(19)30418-0.
Google Scholar
Yombi JC, Mertes H. Treatment as prevention for HIV infection: current data, challenges, and global perspectives. AIDS Rev. 2018;20:131–40. https://doi.org/10.24875/AIDSRev.M18000024.
Google Scholar
Kumi Smith M, Jewell BL, Hallett TB, Cohen MS. Treatment of HIV for the prevention of transmission in discordant couples and at the population level. Adv Exp Med Biol. 2018;1075:125–62. https://doi.org/10.1007/978-981-13-0484-2_6.
Google Scholar
Chen Y, Cao Z, Li J, Chen J, Zhu Q, Liang S, Lan G, Xing H, Liao L, Feng Y, Shao Y, Ruan Y, Chen H. HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study. Virol J. 2023;20:289. https://doi.org/10.1186/s12985-023-02246-1.
Google Scholar
Joint United Nations Programme on HIV/AIDS (UNAIDS). Understanding measures of progress towards the 95-95-95 HIV testing, treatment and viral suppression targets. Geneva; 2023. https://www.unaids.org/sites/default/files/media_asset/progress-towards-95-95-95_en.pdf
Hickey MD, Ayieko J, Kwarisiima D, Opel FJ, Owaraganise A, Balzer LB, Chamie G, Jain V, Peng J, Camlin C, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. Improved viral suppression with streamlined care in the SEARCH study. J Acquir Immune Defic Syndr. 2020;85:571–8. https://doi.org/10.1097/QAI.0000000000002508.
Google Scholar
Bakari HM, Alo O, Mbwana MS, Salim SM, Ludeman E, Lascko T, Ramadhani HO. Same-day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: systematic review and meta-analysis. Pan Afr Med J. 2023;46:92. https://doi.org/10.11604/pamj.2023.46.92.40848.
Google Scholar
Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, Dombrowski JC, Norton WE, Raper JL, Kitahata MM, Saag MS. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59:86–93. https://doi.org/10.1097/QAI.0b013e318236f7d2.
Google Scholar
Crepaz N, Song R, Lyss S, Hall HI. Trends in time from HIV diagnosis to first viral suppression following revised US HIV treatment guidelines, 2012–2017. J Acquir Immune Defic Syndr. 2020;85:46–50. https://doi.org/10.1097/QAI.0000000000002398.
Google Scholar
Joint United Nations Programme on HIV/AIDS (UNAIDS). Country factsheets. Tajikistan; 2023. https://www.unaids.org/en/regionscountries/countries/tajikistan.
Deryabina A. HIV epidemic control in central Asia still has a long way to go. 2019. https://www.un.org/en/un-chronicle/hiv-epidemic-control-central-asia-still-has-long-way-go#:~:text=To%20achieve%20HIV%20epidemic%20control,men%2C%20in%20effective%20prevention%20and.
Center for Prevention and Control of HIV of Sughd Oblast. Annual HIV report (internal). Tajikistan: Sughd; 2023.
Mansfeld M, Ristola M, Klinte J, et al. World Health Organization (Europe); Centre for Health & Infectious Disease Research. 2015. https://iris.who.int/bitstream/handle/10665/152646/WHO-EURO-2015-6477-46243-66894-eng.pdf?sequence=3.
World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization; 2007. https://iris.who.int/handle/10665/43699.
International Organization for Migration (IOM). About migration: IOM defintion of migrant. 2025. https://www.iom.int/about-migration.
Gökengin D. Outcomes and gaps in HIV care for migrants in Europe. Lancet HIV. 2024;11:e793–4. https://doi.org/10.1016/S2352-3018(24)00296-0.
Google Scholar
European Centre for Disease Prevention and Control. HIV and migrants: monitoring implementation of the Dublin declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2017 progress report. 2017. https://www.ecdc.europa.eu/sites/default/files/documents/HIV%20and%20migrants.pdf.
Joint United Nations Programme on HIV/AIDS (UNAIDS). The gap report. Geneva; 2014. https://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf.
Kamenshchikova A, Peters CMM, Nöstlinger C, Rice B, Ford N, Ravasi G, Burns F, Parczewski M, Hoebe CJPA, Dukers N, Seedat F, Mozalevskis A, Bekker L-G, Tugirimana B, Tang J, Marley W, Onyango G, Peynado DT, Noori MC, Hargreaves T. Interventions to ensure access to and continuity of HIV care for international migrants: an evidence synthesis. Lancet HIV. 2024;11:e873–84. https://doi.org/10.1016/S2352-3018(24)00175-9.
Google Scholar
International Organization for Migration (IOM). Tajikistan – migration situation report #1 (January – December 2023). 2024. https://dtm.iom.int/es/node/38791?close=true.
Segala FV, Di Gennaro F, Frallonardo L, De Vita E, Petralia V, Sapienza V, Di Gregorio S, Cormio M, Novara R, Rizzo G, Barbagallo M, Veronese N, Saracino A. HIV-related outcomes among migrants living in Europe compared with the general population: a systematic review and meta-analysis. Lancet HIV. 2024. https://doi.org/10.1016/S2352-3018(24)00210-8.
Google Scholar
Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Rusconi S, Caramello P, Abrescia N, Mussini C, Monno L, d’Arminio Monforte A. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. Clin Microbiol Infect. 2016;22:e2881–8. https://doi.org/10.1016/j.cmi.2015.10.026.
Google Scholar
Amirkhanian YA, Kuznetsova AV, Kelly JA, Difranceisco WJ, Musatov VB, Avsukevich NA, Chaika NA, McAuliffe TL. Male labor migrants in russia: HIV risk behavior levels, contextual factors, and prevention needs. J Immigr Minor Health. 2011;13:919–28. https://doi.org/10.1007/s10903-010-9376-y.
Google Scholar
Weine S, Bahromov M, Mirzoev A. Unprotected Tajik male migrant workers in Moscow at risk for HIV/AIDS. J Immigr Minor Health. 2008;10:461–8. https://doi.org/10.1007/s10903-007-9103-5.
Google Scholar
Weine S, Bahromov M, Loue S, Owens L. HIV sexual risk behaviors and multilevel determinants among male labor migrants from Tajikistan. J Immigr Minor Health. 2013;15:700–10. https://doi.org/10.1007/s10903-012-9718-z.
Google Scholar
Bromberg DJ, Tate MM, Alaei K, Karimov S, Saidi D, Alaei A. Association between time spent in the Russian federation and late presentation for HIV among Tajikistani migrants. BMC Public Health. 2020;20:1379. https://doi.org/10.1186/s12889-020-09434-6.
Google Scholar
Chu C, Tao K, Kouamou V, Avalos A, Scott J, Grant PM, Rhee S-Y, McCluskey SM, Jordan MR, Morgan RL, Shafer RW. Prevalence of emergent dolutegravir resistance mutations in people living with HIV: a rapid scoping review. Viruses. 2024;16. https://doi.org/10.3390/v16030399.
Akbulut I, Varol ZS, Akca V, Serin BG, Erogul E, Odemiş I, Senbayrak S, Atalay S. Multicenter study in Turkiye of unsuppressed viremia in people living with human immunodeficiency virus: Aegean experience. BMC Infect Dis. 2025;25:587. https://doi.org/10.1186/S12879-025-10988-2.
Google Scholar
Ford N, Ehrenkranz P, Jarvis J. Advanced HIV as a neglected disease. N Engl J Med. 2024;390:487–9. https://doi.org/10.1056/NEJMP2313777/SUPPL_FILE/NEJMP2313777_DISCLOSURES.PDF.
Google Scholar
Kantor R, Gupta RK. We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy. Lancet HIV. 2023;10:e202–8. https://doi.org/10.1016/S2352-3018(22)00327-7.
Google Scholar
Schwartz SR, Kavanagh MM, Sugarman J, Solomon SS, Njindam IM, Rebe K, Quinn TC, Toure-Kane C, Beyrer C, Baral S. HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities. J Int AIDS Soc. 2017;20(7). https://doi.org/10.1002/jia2.25003.
Vignier N, Du Lou D, Pannetier A, Ravalihasy J, Gosselin A, Lert A, Lydie F, Bouchaud N, Spira OD, Chauvin R, ed al. Social and structural factors and engagement in HIV care of sub-Saharan African migrants diagnosed with HIV in the Paris region. AIDS Care. 2019;31:897–907. https://doi.org/10.1080/09540121.2019.1576842.
Google Scholar
Ramirez-Ortiz D, Seitchick J, Polpitiya M, Algarin AB, Sheehan DM, Fennie K, Cyrus E, Trepka MJ. Post-immigration factors affecting retention in HIV care and viral suppression in Latin American and Caribbean immigrant populations in the united states: a systematic review. Ethn Health. 2022;27:1859–99. https://doi.org/10.1080/13557858.2021.1990217.
Google Scholar
Zhou C, Wu Y, Zhang Y, Wang Y, Wu H, Zhang T, Chen G, Huang X. Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis. Int J Infect Dis. 2023;129:216–27. https://doi.org/10.1016/j.ijid.2023.01.025.
Google Scholar